An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
| Excerpt | Reference |
|---|
| "Mucositis is a debilitating side-effect of chemotherapy which affects the mucosa of the gastrointestinal tract, particularly the small intestine." | ( Bajka, BH; Butler, RN; Clarke, JM; Howarth, GS; Pelton, NC; Read, LC, 2006) |
| "Alimentary mucositis is a significant complication of cancer therapy, with important clinical and economic implications." | ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006) |
| "Mucositis is a significant complication of cancer therapy, with important clinical and economic implications." | ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006) |
| "The aetiology of mucositis is complex involving change in gene expression, altered apoptosis and interaction between epithelial and subepithelial compartments." | ( Bowen, JM; Cummins, AG; Gibson, RJ; Keefe, DM; Tyskin, A, 2007) |
| "Mucositis is associated with increased intestinal permeability (IP)." | ( Choi, K; Jeon, WK; Kim, JW; Lee, SS; Lim, SY; Oh, SJ; Oh, TY, 2007) |
| "Small intestinal mucositis is a common side-effect following high-dose chemotherapy, causing patients to experience pain and abdominal complications often leading to extended stays in hospital." | ( Butler, RN; Davidson, GP; McNeil, Y; Saxon, BR; Tooley, KL; Webster, J; Zacharakis, B, 2006) |
| "Mucositis is a common, costly and unpleasant side effect of cancer chemotherapy and radiotherapy." | ( Alvarez, E; Bowen, JM; Burns, J; Gibson, RJ; Keefe, DM; Logan, RM; Stringer, AM; Yeoh, AS, 2007) |
| "Intestinal mucositis is a common and debilitating side-effect of chemotherapy, associated with severe small intestinal inflammation." | ( Butler, RN; Geier, MS; Howarth, GS; Smith, CL; Tooley, KL; Torres, DM, 2008) |
| "(1) Oral mucositis is a frequent adverse effect of cancer chemotherapy and radiotherapy." | ( , 2008) |
| "Acute mucositis is a dose-limiting toxicity of concurrent chemoradiotherapy regimens for locally advanced head and neck cancer." | ( Berger, D; Brizel, DM; Brizel, HE; Chen, MG; Glück, S; Mendenhall, W; Meredith, RF; Murphy, BA; Pandya, KJ; Rosenthal, DI, 2008) |
| "The pathobiology of mucositis is complex, and agents that target mechanisms to prevent mucositis or accelerate healing are in high demand." | ( Bowen, JM; Keefe, DM; Sonis, ST, 2008) |
| "Mucositis is a major oncological problem, caused by the cytotoxic effects of cancer chemotherapy and radiotherapy." | ( Bowen, JM; Gibson, RJ; Keefe, DM; Laurence, J; Logan, RM; Stringer, AM; Yeoh, AS, 2009) |
| "Oral mucositis is a major severe toxic side-effect of systemic chemotherapy and irradiation in patients with cancer." | ( Hiramoto, K; Inukai, Y; Kaji, H; Maiguma, T; Makino, K; Ono, H; Teshima, D, 2009) |
| "Mucositis is a common side-effect of high-dose chemotherapy regimens." | ( Bastian, SE; Butler, RN; Cheah, KY; Howarth, GS; Payne, C; Whitford, EJ; Wright, TH; Yazbeck, R, 2009) |
| "Mucositis is an important dose-limiting side effect of methotrexate for which there is no definitive prophylaxis or treatment." | ( Balamtekin, N; Erdem, O; Gulgun, M; Kesik, V; Kismet, E; Koseoglu, V; Kul, M; Oztas, E; Vurucu, S, 2010) |
| "Xerostomia and mucositis are common adverse effects of radiation therapy, and it is critical that good oral hygiene practices are maintained." | ( Belgam, R; Brodzik, FA; Mehdi, S; Scarpace, SL, 2009) |
| "Mucositis is an intestinal mucosal damage of the gastrointestinal tract--mouth, throat, stomach, intestines, rectum, and anus--that is caused directly by chemotherapies and radiotherapies." | ( Noé, JE, 2009) |
| "Gastrointestinal mucositis is a common side effect of cancer chemotherapy." | ( Brito, GA; Cunha, FQ; Justino, PF; Lima-Junior, RC; Mota, JM; Ribeiro, RA; Soares, PM; Souza, MH, 2011) |
| "Mucositis is a painful, debilitating condition affecting the alimentary mucosa and occurs following many anticancer treatments." | ( Hommers, C; Parry, S; Stoddart, PA; White, MC, 2011) |
| "Mucositis is the term used to describe damage caused by chemotherapy to mucous membranes of the alimentary tract." | ( Al-Dasooqi, N; Bowen, JM; Gibson, RJ; Keefe, DM; Logan, RM; Stringer, AM, 2011) |
| "Intestinal mucositis is a serious complication of cancer chemotherapy and radiotherapy; it frequently compromises treatment and dramatically reduces the quality of life of patients." | ( Brinkman, BM; Heyndrickx, L; Kaczmarek, A; Krysko, DV; Vandenabeele, P, 2012) |
| "Therapyrelated mucositis is associated with considerable morbidity." | ( Busemann, C; Dölken, G; Kiefer, T; Krüger, WH; Neumann, T; Wilfert, H, 2011) |
| "Mucositis is a commonly encountered dose-limiting toxicity that often leads to delays in subsequent courses of chemotherapy." | ( Hill, N; Johansson, ÅM; Karlsson, MO; Perisoglou, M; Standing, JF; Whelan, J, 2011) |
| "Mucositis is one of the most frequent side effects induced by chemotherapy that damages the patients' QOL and response rate." | ( Fukuhara, K; Hayaishi, Y; Katsuragi, K; Kodama, S; Morisya, Y; Nakanishi, C; Terakura, M, 2011) |
| "Intestinal mucositis is one of the major troublesome side effects of anticancer chemotherapy leading to poor patient compliance." | ( Araújo, CV; Azevedo, OG; Costa, TB; Guerrant, RL; Lima, AÂ; Lima, RC; Lucena, HB; Oliveira, BC; Oliveira, RA; Oriá, RB; Ribeiro, RA; Vitek, MP; Warren, CA; Wong, DV; Zaja-Milatovic, S, 2012) |
| "Oral mucositis is a serious complication of chemotherapy that results in painful debilitating inflammation, necessitating the administration of analgesics." | ( Ansari Moghadam, A; Arbabi-kalati, F; Deghatipour, M, 2012) |
| "Gastrointestinal mucositis is an unwanted and often dose-limiting side effect to most cancer treatments." | ( Hartmann, B; Holst, JJ; Kissow, H; Poulsen, SS; Thim, L; Timm, M; Viby, NE, 2012) |
| "Mucositis is a known complication following use of chemotherapy, but fatal mucositis is unusual and management of such cases may be challenging." | ( Choudhary, D; Dhamija, G; Gupta, N; Handoo, A; Sharma, SK, 2013) |
| "Alimentary mucositis is a severe, dose-limiting, toxic side effect of cytotoxic chemotherapy and radiotherapy." | ( Butler, R; Stringer, A; Thorpe, D, 2013) |
| "Mucositis is a debilitating intestinal side effect of chemotherapeutic regimens." | ( Brook, CL; Howarth, GS; Lawrence, A; Wang, H; Whittaker, AL; Yazbeck, R, 2013) |
| "Gastrointestinal mucositis is one of the most prevalent side effects of chemotherapy." | ( Itoh, T; Kajiwara, E; Nasu, R; Nishida, R; Yamamoto, A, 2013) |
| "Intestinal mucositis is a common side-effect of irinotecan-based cancer chemotherapy regimens." | ( Brito, GA; Cunha, FQ; Freitas, HC; Leite, LL; Lima-Júnior, RC; Magalhães, PJ; Miranda, SP; Nunes, LG; Ribeiro, RA; Souza, MH; Teixeira, MM; Wanderley, CW; Wong, DV, 2014) |
| "Gastrointestinal mucositis is a frequent complication of antineoplastic chemotherapy, but the effects of chemotherapy on mucosal defense mechanisms remain poorly understood." | ( Ichikawa, T; Ishihara, K; Koizumi, W; Takeda, Y; Yamamoto, H, 2013) |
| "Mucositis is a serious disorder of the gastrointestinal tract that results from cancer chemotherapy." | ( Bastian, SE; Cheah, KY; Howarth, GS, 2014) |
| "Intestinal mucositis is an important toxic side effect of 5-fluorouracil (5-FU) treatment." | ( Costa, JV; Costa, MR; Franco, AX; Justino, PF; Lima, AA; Melo, LF; Mendes, WO; Nogueira, AF; Ribeiro, RA; Santos, CM; Silva, LM; Soares, PM; Souza, MH, 2014) |
| "Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy." | ( Barasch, A; Bowen, J; Elad, S; Elting, L; Epstein, J; Keefe, DM; Lalla, RV; McGuire, DB; Migliorati, C; Nicolatou-Galitis, O; Peterson, DE; Raber-Durlacher, JE; Sonis, ST, 2014) |
| "Oral mucositis is a common side effect of chemotherapy drugs and is characterized by erythema, pain, poor oral intake, pseudomembranous destruction, open ulceration and hemorrhage of the oral mucosa." | ( Akdeniz, N; Calka, O; Ozkol, HU; Toptas, T, 2015) |
| "Oral mucositis is a major cause of morbidity in high-dose therapy/autologous stem cell transplantation (HDT/ASCT), where microbial colonization has an important pathological implication." | ( François, S; Hamel, JF; Hunault-Berger, M; Ifrah, N; Mercier, M; Moal, F; Moles-Moreau, MP; Orvain, C; Parot-Schinkel, E; Tanguy-Schmidt, A, 2015) |
| "Mucositis is a common and serious side-effect experienced by cancer patients during treatment with chemotherapeutic agents." | ( Howarth, GS; Lymn, KA; Nicholson, A; Whittaker, AL, 2015) |
| "Intestinal mucositis is a common side-effect in patients who receive aggressive chemotherapy." | ( Berkowitz, D; Coran, AG; Geyer, T; Mogilner, JG; Pollak, Y; Sukhotnik, I, 2014) |
| "Intestinal mucositis is a common toxic side effect in cancer patients receiving high-dose chemotherapy." | ( Chong, P; Feng, WD; Shi, HP; Xue, CL; Yang, T; Yu, HL; Yu, M; Yuan, KT, 2015) |
| "Mucositis is a common problem that results from cancer chemotherapy and is a cause of significant morbidity and occasional mortality." | ( Chang, Y; Duan, G; Li, X; Tang, Q; Xue, C; Yu, L; Zheng, R; Zuo, T, 2015) |
| "Mucositis is as an important determinant of the inflammatory response and infectious complications in cancer treated patients." | ( Anuszewska, E; Barzał, JA; Jaworska, M; Rzepecki, P; Szczylik, C, 2014) |
| "Mucositis is a common complication in patients undergoing radiotherapy and chemotherapy." | ( Alvarez-Leite, JI; Antunes, MM; Cara, DC; Cardoso, VN; Correia, MI; Generoso, Sde V; Leocádio, PC; Leonel, AJ; Menezes, GB; Teixeira, LG, 2016) |
| "Mucositis is a serious disorder of the gastrointestinal tract that results from cancer chemotherapy." | ( Anghel, N; Balta, C; Cotoraci, C; Herman, H; Hermenean, A; Mariasiu, T; Miutescu, E; Rosu, M; Sasu, A, 2015) |
| "Mucositis is a side effect of chemotherapy treatment that affects approximately 40% of patients." | ( Alvarez-Leite, JI; Antunes, MM; Cardoso, VN; Correia, MI; Generoso, SV; Leocádio, PC; Leonel, AJ; Machado, DC; Teixeira, LG, 2015) |
| "Mucositis is a major oncological problem." | ( Bateman, E; Keefe, D; Mayo, B; Stringer, A; Thorpe, D; Vanhoecke, B; Vanlancker, E, 2015) |
| "Intestinal mucositis is a frequent side-effect of chemotherapy treatment." | ( Howarth, GS; Leach, MC; Lymn, KA; Preston, FL; Whittaker, AL, 2016) |
| "Mucositis is one of the most debilitating side effects of chemotherapy and some previous studies suggest a role for indigenous microbiota in the course of this pathology." | ( Arantes, RME; Bastos, RW; Cardoso, VN; Cartelle, CT; Generoso, SV; Martins, FS; Nicoli, JR; Oliveira, JS; Pedroso, SHSP; Soares, PMG; Teixeira, MM; Vieira, AT, 2015) |
| "Intestinal mucositis is a frequently encountered side effect in oncology patients undergoing chemotherapy." | ( Chan, WT; Chang, SW; Cheng, ML; Chiang Chiau, JS; Jiang, CB; Lee, HC; Liu, CY; Yeung, CY, 2015) |
| "Intestinal mucositis is a common side effect of irinotecan-based anticancer regimens." | ( Almeida, PR; Batista, GL; Bem, AX; Borges, VF; Brito, GA; Carvalho, CB; Cunha, FQ; Cunha, TM; Leite, CA; Lima-Júnior, RC; Ribeiro, RA; Silva, RL; Teixeira, MA; Wanderley, CW; Wong, DV, 2015) |
| "Intestinal mucositis is a serious toxic side effect of 5-fluorouracil (5-FU) treatment." | ( Gou, H; Gu, LY; Shang, BZ; Wang, C; Xiong, Y, 2016) |
| "Gastrointestinal mucositis is a major and serious side effect of cancer therapy, and there is no effective therapy for this clinical condition." | ( Arantes, RM; Bastos, RW; Cardoso, VN; Cartelle, CT; França, CS; Generoso, SV; Martins, FS; Moreira, LM; Neves, MJ; Nicoli, JR; Pedroso, SH; Vieira, AT, 2016) |
| "Intestinal mucositis is one of the major problems in the patients receiving cancer treatment." | ( Altuner, D; Arslan, A; Cetin, N; Cimen, FK; Coban, TA; Kuzucu, M; Nalkiran, HS; Ozcicek, A; Suleyman, B; Suleyman, H, 2016) |
| "Mucositis is a common side effect of cancer therapies that causes painful, erythematous lesions to develop in the gastrointestinal tract." | ( Wodzinski, A, 2016) |
| "Mucositis is the most common side effect due to chemotherapy or radiotherapy." | ( Andrade, ME; Barros, PA; Cardoso, VN; da Gama, MA; de Sales E Souza, ÉL; Fernandes, SO; Generoso, SV; Lopes, FC; Martins, FD; Miranda, SE, 2017) |
| "Intestinal mucositis is an inflammatory process occurring in the intestinal mucosa and is a common side effect of irinotecan hydrochloride (CPT-11) based anticancer regimens." | ( Alvarenga, EM; Araújo, AR; Araújo, TS; de C Brito, GA; Martins, CS; Medeiros, JV; Nogueira, KM; Pacífico, DM; Sousa, DP; Sousa, FB; Souza, EP; Souza, LK, 2016) |
| "Mucositis is a significant complication of intensive chemotherapy or hematopoietic cell transplantation (HCT), with few treatment options." | ( Craig, M; Cumpston, A; Hamadani, M; Kanate, AS; Shillingburg, A; Wen, S, 2017) |
| "Mucositis is one of the most relevant gastrointestinal inflammatory conditions in humans, generated by the use of chemotherapy drugs, such as 5-fluoracil (5-FU)." | ( Azevedo, V; Bermúdez-Humarán, LG; Breyner, N; Carmona, D; Carvalho, RD; Chatel, JM; da Gloria Souza, D; de Azevedo, MS; de Faria, AM; Figueiredo, HC; Langella, P; Lemos, L; Maioli, TU; Menezes-Garcia, Z; Rodrigues, NM, 2017) |
| "Oral mucositis is a common adverse effect of chemotherapy that limits the required dose of chemotherapeutic agents." | ( Asano, RT; Fujimoto, SI; Imano, M; Itoh, T; Matsuda, T; Nishida, S; Satou, T; Takeda, T; Tsubaki, M, 2018) |
| "Oral mucositis is still one of the most painful side effects of chemotherapeutic treatment and a mounting body of evidence suggests a key role for the oral microbiome in mucositis development." | ( Beterams, A; Bourgeois, J; De Moerloose, B; De Vos, WH; Sieprath, T; Van de Wiele, T; Vanhoecke, B; Vanlancker, E, 2018) |
| "Mucositis is a common adverse effect of cytotoxic anticancer treatment with serious implications for the quality of life, morbidity and mortality of cancers patients." | ( Rathe, M; Sangild, PT; Shen, RL, 2018) |
| "Radiation-induced mucositis is a common toxicity, especially in patients with head and neck cancers." | ( Annede, P; Blanchard, P; Bockel, S; Bourdis, M; Chargari, C; Deutsch, É; Drouet, M; François, S; Le Gallic, C; Lévy, A; Magné, N; Riccobono, D; Tao, Y; Vallard, A, 2018) |
| "Mucositis is a side effect of chemotherapy seen in the digestive tract, with symptoms including pain, diarrhoea, inflammation and ulcerations." | ( Balk-Møller, E; Hartmann, B; Holst, JJ; Hytting-Andreasen, R; Kissow, H; Pedersen, J; Windeløv, JA, 2018) |
| "Mucositis is an inflammatory condition of the gut, caused by an adverse effect of chemotherapy drugs, such as 5-fluorouracil (5-FU)." | ( Aguiar, E; Azevedo, V; Bermudez, L; Carvalho, R; Chatel, JM; Dorella, F; Fernandes, G; Figueiredo, H; Goes-Neto, A; Langella, P; Pereira, FL; Vaz, A, 2018) |
| "Oropharyngeal mucositis is considered to be an inevitable and the most troubling side effect of head and neck irradiation, which is caused by the direct toxic action of radiation on oral mucosa." | ( Chen, H; Chen, WQ; Li, XE; Shuai, T; Tian, X; Yi, LJ, 2018) |
| "Gastrointestinal mucositis is a serious side effect of chemotherapy." | ( Cheng, YW; Huang, SH; Huang, WK; Hung, CH; Kang, JJ; Liao, PL; Tsai, CH; Wang, HP, 2019) |
| "Irinotecan-induced mucositis is a major oncological problem." | ( Stringer, A; Sultani, M; Thorpe, D, 2019) |
| "Irinotecan-induced mucositis is a major oncological problem." | ( Butler, R; Stringer, A; Sultani, M; Thorpe, D; Vanhoecke, B, 2020) |
| "Gastrointestinal mucositis is a major problem associated with cancer therapy." | ( Almeida-Leite, CM; Alvarez-Leite, JI; Cardoso, VN; Generoso, SV; Leocádio, PCL; Martins, FS; Monteiro, CF; Nicoli, JR; Pessione, E; Porto, BAA; Santos, DA; Santos, JRA; Souza, ÉLS, 2019) |
| "Mucositis is often experienced in metastatic renal cell carcinoma (mRCC) patients treated with targeted therapies." | ( Donskov, F; Fristrup, N, 2019) |
| "Mucositis is a common and therapy-limiting adverse effect of cancer treatments including radiotherapy, chemotherapy, and immunotherapy." | ( Thomsen, M; Vitetta, L, 2019) |
| "Intestinal mucositis is an important problem in the patients receiving cancer treatment." | ( Akbas, EM; Cankaya, M; Kara, AV; Kurt, N; Mammadov, R; Ozcicek, A; Ozcicek, F; Suleyman, H; Yazici, GN, 2020) |
| "Intestinal mucositis is the most common side effect of 5-fluorouracil (5-Fu) treatment in cancer patients." | ( Li, M; Liu, D; Xiang, DC; Xu, YJ; Yang, JY; Zhang, CL; Zhang, S; Zhu, C, 2020) |
| "Oral mucositis is a common inflammatory complication among patients with cancer." | ( Andisheh-Tadbir, A; Badie, A; Habibagahi, R; Haghnegahdar, S; Koohi-Hosseinabadi, O; Tanideh, N, 2020) |
| "Gastrointestinal mucositis is a common and debilitating side-effect of anticancer therapy contributing to dose reductions, delays and cessation of treatment, greatly impacting clinical outcomes." | ( Al Thaalibi, M; McQuade, RM; Nurgali, K, 2020) |
| "Intestinal mucositis is an important adverse effect of antineoplastic therapy, which remains without adequate treatment." | ( Boeing, T; da Silva, LM; de Souza, P; Gois, MB; Sant Ana, DMG; Somensi, LB, 2021) |
| "Mucositis is an inflammation of the gastrointestinal mucosa resulting from high doses of radio/chemotherapy treatment and may lead to interruption of antineoplasic therapy." | ( Andre, LC; Azevedo, V; Cardoso, VN; d'Auriol-Souza, MM; Gallotti, B; Galvao, I; Jesus, LCL; Leles, G; Martins, FS; Mendes, V; Miranda, VC; Quintanilha, MF; Rocha, VM; Souza, RO; Trindade, LM; Vieira, AT, 2021) |
| "Mucositis is a common side-effect of chemotherapy treatment, inducing alterations in the composition of the gut microbiota." | ( da Silva Ferreira, AR; Harmsen, HJM; Havinga, R; Tissing, WJE; Wardill, HR, 2020) |
| "However, intestinal mucositis is the most frequently occurring side effect of cancer therapy with 5-FU." | ( Chang, CW; Chen, YJ; Hsieh, CH; Liu, CY; Liu, JH; Tsai, TH, 2021) |
| "Mucositis is one of the most adverse effects of 5-fluorouracil (5-FU) and had no standard drug for treatment." | ( Boonsiri, P; Chio-Srichan, S; Daduang, J; Lee, YC; Leelayuwat, C; Mahakunakorn, P; Priprem, A; Puthongking, P; Settasatian, C; Tippayawat, P; Uthaiwat, P, 2021) |
| "Mucositis is one of the most strenuous side effects caused by chemotherapy drugs, such as 5-fluorouracil (5-FU), during the treatment of several types of cancers." | ( Campos, MRA; Cardoso, VN; Coutinho, JOPA; de Menezes, GCA; Fernandes, SOA; Ferreira, E; Martins, FS; Nicoli, JR; Quintanilha, MF; Rosa, CA; Rosa, LH; Tiago, FCP; Vital, KD, 2022) |
| "Intestinal mucositis is a common side effect of the chemotherapeutic agent doxorubicin, which is characterized by severe Toll-like receptor (TLR) 2-mediated inflammation." | ( Beukema, M; de Haan, BJ; de Vos, P; Faas, MM; Jermendi, É; Kitaguchi, K; Koster, T; Schols, HA; van den Berg, MA, 2021) |
| "Mucositis is a serious adverse effect of chemotherapeutic treatment." | ( Detlefsen, S; Holmskov, U; Husby, S; Jiang, PP; Nexoe, AB; Pedersen, AA; Rathe, M; Sorensen, GL; von Huth, S, 2021) |
| "Intestinal mucositis is a commonly encountered toxic side effect in patients undergoing 5-fluorouracil (5-FU)-based chemotherapy." | ( Chen, WJ; Chu, HF; Shen, SR; Shen, TL; Wang, YR; Wu, SH, 2021) |
| "Mucositis is a common side effect of cancer therapies and transplant conditioning regimens." | ( Aslan, K; Azizoglu, ZB; Deniz, K; Erdem, S; Haliloglu, Y; Karakukcu, M; Patiroglu, T; Per, S; Suna, PA; Tasdemir, A; Unal, E; Yay, AH; Yilmaz, E, 2022) |
| "However, intestinal mucositis is a well-known adverse event of 5-FU, which limits its therapeutic use." | ( Al-Amin, MA; Al-Khrashi, LA; Badr, AM; Mahran, YF, 2022) |
| "Intestinal mucositis is a common side effect of cancer chemotherapy and it limits the dose of chemotherapy given to a patient." | ( Wang, Q; Zhao, W, 2021) |
| "Management of mucositis is essential for the long-term maintenance of dental implants." | ( Cosola, S; Covani, U; Genovesi, A; Giammarinaro, E; Marconcini, S; Oldoini, G, 2022) |
| "Intestinal mucositis is a common side effect of chemotherapy and radiotherapy." | ( Deng, S; Li, J; Li, L; Wu, D; Xu, Y, 2021) |
| "Intestinal mucositis is one of chemotherapeutics' most common adverse effects, such as 5-fluorouracil (5-FU)." | ( Barary, M; Ebrahimpour, A; Hosseini, SM; Hosseinzadeh, R; Kazemi, S; Lotfi, M; Moghadamnia, AA; Shirafkan, F; Sio, TT, 2021) |
| "Gastrointestinal mucositis is a complication of anticancer treatment, with few validated in vitro systems suitable to study the complex mechanisms of mucosal injury." | ( da Silva Ferreira, AR; Garssen, J; Harmsen, HJM; Harthoorn, LF; Hartog, A; Ten Klooster, JP; Tissing, WJE; van Bergenhenegouwen, J; van der Aa, SAJ; Wardill, HR; Wehkamp, T, 2021) |
| "Mucositis is a major clinical complication associated with cancer treatment and may limit the benefit of chemotherapy." | ( Arifa, RDN; Barcelos, LS; Brito, CB; Cassini-Vieira, P; da Silva, JM; da Silva, TA; de Paula, TP; Fagundes, CT; Lima, RL; Menezes-Garcia, Z; Queiroz-Junior, CM; Souza, DG; Teixeira, MM; Vilas Boas, FA, 2022) |
| "Gastrointestinal mucositis is a common and dose-limiting side effect characterized by ulcerative lesions in the mucosa of the digestive tract in patients receiving anticancer drugs such as 5-fluorouracil (5-FU), a potent antineoplastic drug." | ( Abacioglu, N; Chukwunyere, U; Mercan, M; Sehirli, AO, 2022) |
| "Intestinal mucositis is characterized by inflammation and ulceration of the mucosa that affects the gastrointestinal tract and is associated with administering some drugs, such as 5- Fluorouracil (5-FU), conventional chemotherapy used in clinics for cancer therapy." | ( Araújo, DD; da Silva Souza, B; de Andrade, GL; de Freitas, CDT; de Oliveira, JS, 2023) |
| "Mucositis is a common and most debilitating complication associated with the cytotoxicity of chemotherapy." | ( Cirillo, N; Huang, J; Hwang, AYM; Iskandar, M; Jia, Y; Kim, B; Mohammed, AI, 2022) |
| "Mucositis is a common and most debilitating complication associated with the cytotoxicity of chemotherapy." | ( Cirillo, N; Huang, J; Hwang, AYM; Iskandar, M; Jia, Y; Kim, B; Mohammed, AI, 2022) |
| "Mucositis is defined as inflammatory and ulcerative lesions along of the gastrointestinal tract that leads to the imbalance of the intestinal microbiota." | ( Andrade, MER; Cardoso, VN; Cassali, GD; Cavalcante, GG; da Silva, TF; de Carvalho Azevedo, VA; de Oliveira Carvalho, RD; de Oliveira, JS; Dos Reis, DC; Fernandes, SOA; Generoso, SV; Leite, JIA; Leocádio, PCL; Trindade, LM, 2023) |
| "Oral and intestinal mucositis are debilitating inflammatory diseases observed in cancer patients undergoing chemo-radiotherapy." | ( Celentano, A; Cirillo, N; Low, JT; McCullough, MJ; Mohammed, AI; O' Reilly, LA; Paolini, R, 2023) |
| "Oral mucositis is a common side effect of cancer treatment, and in particular of treatment with the mTORC1 inhibitor everolimus." | ( Fei, Q; Lambros, M; Moreno, J; Orlando, R; Parsa, C; Van Haute, L, 2023) |
| "Mucositis is among the most common side effects of 5-Fluorouracil (5-FU) and other cancer therapeutic drugs." | ( Hosseini, SM; Kazemi, S; Lotfi, M; Madani, F; Moghadamnia, AA; Shirafkan, F, 2023) |
| "Intestinal mucositis is a commonly reported side effect in oncology patients undergoing chemotherapy and radiotherapy." | ( Américo, MF; Azevedo, V; Barroso, FAL; Batista, VL; Belo, GA; Birbrair, A; Campos, GM; Cardoso, VN; Coelho-Rocha, ND; da Silva, TF; de Jesus, LCL; Dos Santos Freitas, A; Drumond, MM; Fernandes, SOA; Ferreira, E; Laguna, JG; Mancha-Agresti, P; Martins, FS; Tavares, LM; Vital, KD, 2023) |
| "Oral mucositis is a common but potentially debilitating complication of stem cell transplant, requiring opioid analgesia in a significant number of cases." | ( Abbas, Y; Ali, M; Hussain, M; Kerio, AA; Khan, MA; Khattak, TA, 2023) |